Atossa Therapeutics, Inc. (ATOS) has 18 已知的内部人和机构持有人记录. 最大持有人为 Guse Kyle 持有 557,900 股. 其他重要持有人包括 Rees Heather 和 Chen Ben R.
过去12个月，内部人进行了 15 笔交易，涉及 ATOS 股票 — 14 笔买入 (价值为 $3.24M) 和 0 笔卖出 (价值为 RSU 奖励). 内部人买入超过卖出，可能表明对公司前景有信心.
ATOS 內部人持股
最大持股人
Guse Kyle
557,900 股
主要內部人持股
| # |
姓名 |
职位 |
持股数量 |
最近申报日期 |
相对规模 |
| 1 |
Guse Kyle |
CFO, Gen Counsel and Secretary |
557,900 |
2023-03-06 |
|
| 2 |
Rees Heather |
Chief Financial Officer |
543,785 |
2025-05-16 |
|
| 3 |
Chen Ben R |
Sr. VP of Glob. Reg. Affairs |
300,000 |
2014-04-03 |
|
| 4 |
Youmans Scott |
Chief Operating Officer |
286,217 |
2015-09-03 |
|
| 5 |
Chen Shu-chih |
Director |
125,000 |
2025-05-16 |
|
| 6 |
Finn Jonathan |
Director |
125,000 |
2025-05-16 |
|
| 7 |
Remmel H. Lawrence |
Director |
125,000 |
2025-05-16 |
|
| 8 |
Steinhart Richard I |
Director |
125,000 |
2025-05-16 |
|
| 9 |
Cigler Tessa |
Director |
125,000 |
2025-05-16 |
|
| 10 |
Galli Stephen J |
Director |
125,000 |
2025-05-16 |
|
| 11 |
Cross Alexander D |
Director |
88,866 |
2013-06-27 |
|
| 12 |
Quay Steven C |
President & CEO |
88,038 |
2026-03-31 |
|
| 13 |
Daniel Mark James |
Chief Financial Officer |
63,000 |
2026-03-30 |
|
| 14 |
Sawyer John E |
See Remarks |
59,265 |
2015-03-18 |
|
| 15 |
Destro Christopher S. |
SVP, Sales and Marketing |
54,625 |
2015-03-18 |
|
| 16 |
Carbonaro Peter J. |
Sr. Vice President, Operations |
45,000 |
2014-05-08 |
|
| 17 |
Barnhart John |
Director |
44,882 |
2013-05-09 |
|
| 18 |
Weaver Gregory L |
Former EVP, CFO, & Director |
55 |
2023-11-17 |
|
近期交易 (过去12个月)
| 日期 |
姓名 |
职位 |
类型 |
股数 |
股价 |
总价值 |
| 2026-03-27 |
Quay Steven C |
President & CEO |
限制性股票授予 (RSU) |
65,000 |
- |
- |
| 2026-03-26 |
Daniel Mark James |
Chief Financial Officer |
限制性股票授予 (RSU) |
63,000 |
- |
- |
| 2026-01-20 |
Quay Steven C |
President & CEO |
限制性股票授予 (RSU) |
331,674 |
- |
- |
| 2026-01-20 |
Quay Steven C |
President & CEO |
限制性股票授予 (RSU) |
325,203 |
- |
- |
| 2025-10-14 |
Daniel Mark James |
Chief Financial Officer |
限制性股票授予 (RSU) |
578,000 |
$1.03 |
$595.34K |
| 2025-10-14 |
Daniel Mark James |
Officer |
未知 |
- |
- |
- |
| 2025-05-21 |
Quay Steven C |
President & CEO |
知情买入 |
11,239 |
$0.88 |
$9.89K |
| 2025-05-15 |
Cigler Tessa |
Director |
限制性股票授予 (RSU) |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Rees Heather |
Chief Financial Officer |
限制性股票授予 (RSU) |
543,785 |
$0.99 |
$538.35K |
| 2025-05-15 |
Finn Jonathan |
Director |
限制性股票授予 (RSU) |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Chen Shu-chih |
Director |
限制性股票授予 (RSU) |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Galli Stephen J |
Director |
限制性股票授予 (RSU) |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Remmel H. Lawrence |
Director |
限制性股票授予 (RSU) |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Steinhart Richard I |
Director |
限制性股票授予 (RSU) |
125,000 |
$0.99 |
$123.75K |
| 2025-05-15 |
Quay Steven C |
President & CEO |
限制性股票授予 (RSU) |
1,366,062 |
$0.99 |
$1.35M |
